ANVS
Price:
$4.65
Market Cap:
$91.48M
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Industry
Biotechnology
IPO Date
2020-01-29
Stock Exchange
NYSE
Ticker
ANVS
According to Annovis Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -17038803690.00. This represents a change of 302.31% compared to the average of -4235294297.43 of the last 4 quarters.
The mean historical Enterprise Value of Annovis Bio, Inc. over the last ten years is 71.61M. The current -17038803690.00 Enterprise Value has changed -2379347.98% with respect to the historical average. Over the past ten years (40 quarters), ANVS's Enterprise Value was at its highest in in the June 2021 quarter at 581.24M. The Enterprise Value was at its lowest in in the June 2025 quarter at -17088000878.73.
Average
71.61M
Median
58.43M
Minimum
39.50M
Maximum
162.98M
Discovering the peaks and valleys of Annovis Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 123.77%
Maximum Annual Enterprise Value = 162.98M
Minimum Annual Increase = -68.88%
Minimum Annual Enterprise Value = 39.50M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 50.72M | -68.88% |
| 2023 | 162.98M | 100.61% |
| 2022 | 81.24M | -8.08% |
| 2021 | 88.38M | 123.77% |
| 2020 | 39.50M | -40.29% |
| 2019 | 66.14M | 56.88% |
| 2018 | 42.16M | 0.86% |
The current Enterprise Value of Annovis Bio, Inc. (ANVS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
98.31M
5-year avg
84.56M
10-year avg
71.61M
Annovis Bio, Inc.’s Enterprise Value is less than Reviva Pharmaceuticals Holdings, Inc. (30.06M), less than PolyPid Ltd. (31.37M), less than Celularity Inc. (112.66M), less than BioAtla, Inc. (47.72M), less than Evaxion Biotech A/S (29.95M), less than Actinium Pharmaceuticals, Inc. (-7013958.00), greater than PDS Biotechnology Corporation (-26077209422.00), less than BioXcel Therapeutics, Inc. (136.96M), less than Elutia Inc. (54.96M), less than MAIA Biotechnology, Inc. (34.29M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 30.06M | $40.31M | |
| 31.37M | $40.15M | |
| 112.66M | $47.46M | |
| 47.72M | $49.86M | |
| 29.95M | $33.41M | |
| -7013958.00 | $45.23M | |
| -26077209422.00 | $43.78M | |
| 136.96M | $45.71M | |
| 54.96M | $29.45M | |
| 34.29M | $44.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annovis Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Annovis Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Annovis Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Annovis Bio, Inc. (ANVS)?
What is the 3-year average Enterprise Value for Annovis Bio, Inc. (ANVS)?
What is the 5-year average Enterprise Value for Annovis Bio, Inc. (ANVS)?
How does the current Enterprise Value for Annovis Bio, Inc. (ANVS) compare to its historical average?